PlantFuel Life Inc.

PlantFuel Life Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every six (6) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 29,438,495 common shares.

The name and symbol will not change.

28/04/2021

2021-0448 –Name and Symbol Change - Sire Bioscience Inc. (SIRE)

le 28 avril/april 2021

Sire Bioscience Inc. has announced a name and symbol change to PlantFuel Life Inc. (FUEL)

Shares will begin trading under the new name and symbol and with a new CUSIP number on April 30, 2021.

Disclosure documents are available at www.thecse.com

Please note that all open orders will be cancelled at the end of business on April 29, 2021. Dealers are reminded to re-enter their orders.

________________________

23/02/2021

2021-0242 - Reinstatement – Sire Bioscience Inc. (SIRE)

le 23 février/February 2021

Effective immediately, Sire Bioscience Inc. will be reinstated for trading.

The Company has rectified the default situation that gave rise to the suspension.

____________________________

À compter de maintenant Sire Bioscience Inc. sera rétablie à des fins de négociation.

La Société a rectifié la situation de défaut ayant donné lieu à la suspension.

04/02/2021

2021-0214 – Suspensions

le 4 février/February 2021

Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.

For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca

13/10/2020

2020-1018 – Consolidation - Sire Bioscience Inc. (SIRE)

Le 13 octobre/October 13, 2020

Sire Bioscience Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidation common shares for every ten (10) pre-consolidation common shares.

As a result, the outstanding shares of the company will be reduced to approximately 42,423,597 common shares.

The name and symbol will not change.

09/09/2019

2019-0908 – Fundamental Change - Blox Labs Inc./Sire Bioscience Inc.

le 9 septembre/September 2019

Sire Bioscience Inc., the issuer resulting from a Fundamental Change of Blox Labs Inc., has been approved for listing.

Listing and disclosure documents are available at www.thecse.com.

Sire Bioscience Inc. is a life sciences company focused on the cultivation, production and sale of industrial hemp.

25/06/2018

2018-0625 - Stock Split - Blox Labs Inc. (BLOX)

Le 25 Juin /June 2018

Blox Labs Inc. has announced it is undertaking a three for one stock split of its issued and outstanding common shares. Each shareholder of record as of the close of business on the record date will receive two additional shares for each share held on such date.

The shares will begin trading on a split basis (ex-distribution) on June 27, 2018.

Upon completion of the split, there will be approximately 117,413,997 shares issued and outstanding.

17/11/2017

2017-1109 – Name and Symbol Change and Consolidation - Big Rock Labs Inc. (BLA)

November 17, 2017

Big Rock Labs Inc. has announced a name change to Blox Labs Inc. and a share consolidation of its issued and outstanding common shares on a one (1) post consolidation share for each two (2) pre-consolidation common shares.

As a result, the outstanding shares of the company will be reduced to approximately 10,115,000.

The shares will begin trading under the new name and symbol on November 21, 2017.

29/05/2014

2014-0517 – New Listing – Big Rock Labs Inc. (BLA)

New Listing – Big Rock Labs Inc.

CSE Filings

File	Type	Date
Form 7 - February 2023	Monthly Progress Report	06/03/2023
Form 11 - Notice of Option Grant	Proposed Stock Option	13/02/2023
FUEL Option Cancellation	Other	13/02/2023
Certificate of Compliance	Certificate of compliance	10/02/2023
Form 9 - Debt Settlement - Amended	Notice of Issuance or Proposed Issuance of Listed Securities	09/02/2023
Certificate of Compliance	Certificate of compliance	09/02/2023
Form 9 - Debt Settlement	Notice of Issuance or Proposed Issuance of Listed Securities	08/02/2023
Form 7 - January 2023	Monthly Progress Report	02/02/2023
Certificate of Compliance	Certificate of compliance	31/01/2023

1
2
3
4
5
6
7
8
9
…
next ›
last »

You are here